Provided by Tiger Trade Technology Pte. Ltd.

Cytek BioSciences

4.48
+0.08001.82%
Pre-market: 4.43-0.0500-1.12%08:52 EST
Volume:1.40M
Turnover:6.23M
Market Cap:575.90M
PE:-8.60
High:4.57
Open:4.24
Low:4.21
Close:4.40
52wk High:6.18
52wk Low:2.37
Shares:128.55M
Float Shares:108.84M
Volume Ratio:2.40
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5209
EPS(LYR):-0.5209
ROE:-18.05%
ROA:-5.25%
PB:1.69
PE(LYR):-8.60

Loading ...

Analysts Are Neutral on Top Healthcare Stocks: Puma Biotechnology (PBYI), Cytek Biosciences (CTKB)

TIPRANKS
·
Feb 27

Cytek Biosciences Q4 EPS $(0.34) Misses $(0.02) Estimate, Sales $62.141M Beat $57.187M Estimate

Benzinga
·
Feb 27

BRIEF-Cytek Biosciences Q4 Pretax Profit USD -4.031 Million

Reuters
·
Feb 27

Cytek Biosciences Q4 Adjusted Gross Margin 53%

THOMSON REUTERS
·
Feb 27

Cytek Biosciences Q4 Adjusted Ebitda USD 4.491 Million

THOMSON REUTERS
·
Feb 27

Press Release: Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

Dow Jones
·
Feb 27

Cytek Biosciences Inc expected to post a loss of 4 cents a share - Earnings Preview

Reuters
·
Feb 25

Cytek Biosciences Projects 2025 Revenue at Approximately $201 Million

Reuters
·
Jan 15

Cytek Biosciences to Present at J.P. Morgan Healthcare Conference

Reuters
·
Jan 14

Cytek Biosciences prelim Q4 revenue beats estimates

Reuters
·
Jan 12

Cytek Biosciences Expects 2025 Revenue of Approximately $201 Million

Reuters
·
Jan 12

Cytek Biosciences Q4 Revenue USD 62 Million VS. Ibes Estimate USD 57.3 Million

THOMSON REUTERS
·
Jan 12

Cytek Biosciences Expects Total Revenue for the FY 2025 to Be About $201 Mln

THOMSON REUTERS
·
Jan 12

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

THOMSON REUTERS
·
Jan 12

Morgan Stanley Raises Price Target on Cytek Biosciences to $6 From $4, Keeps Equalweight Rating

MT Newswires Live
·
Dec 02, 2025

Cytek Biosciences Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Nov 12, 2025

Cytek Biosciences to Join Piper Sandler Annual Healthcare Conference

Reuters
·
Nov 07, 2025

Stock Track | Cytek BioSciences Soars 6.48% as Q3 Earnings Beat Expectations

Stock Track
·
Nov 06, 2025

Cytek Q3 2025 Earnings Call Summary and Q&A Highlights: APAC Growth and Reagent Expansion Amid EMEA Challenges

Earnings Call
·
Nov 06, 2025

Cytek (CTKB) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Nov 06, 2025